| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/08/2004 | US20040067873 Compolex of apolipoproteins and sphingomyelins; anticholesterol agents |
| 04/08/2004 | US20040067527 A conjugate of an acrylamide based polymer, capable of being taken up by a cell, linked to a biologically active polypeptides and conjugate capable of intracellular delivery of polypeptide while retaining its activity |
| 04/08/2004 | US20040067265 Method for producing tablets from plant extracts |
| 04/08/2004 | US20040067261 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 04/08/2004 | US20040067257 Pharmaceutical formulation |
| 04/08/2004 | US20040067256 Novel modified release formulation |
| 04/08/2004 | US20040067254 Paroxetine compositions and processes for making the same |
| 04/08/2004 | US20040067252 Novel modified release formulation |
| 04/08/2004 | US20040067244 Nano oil in glycerin emulsion |
| 04/08/2004 | US20040067243 Enhancedly-solubilized beta-hydroxy acids and higher potency skin peels formulated therefrom |
| 04/08/2004 | US20040067240 Therapeutic agent comprising a b-subunit of a protein toxin |
| 04/08/2004 | US20040067217 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 04/08/2004 | US20040067216 Drugs comprising ion exchange resins complexed with heterocyclic amines, used for prophylaxis or prevention of viral diseases such as acquired immune deficiency syndrome |
| 04/08/2004 | US20040067213 Mixtures of acylated amino acids and protein condensates used as emulsifiers and/or foaming agents |
| 04/08/2004 | US20040067211 Emulsion composition |
| 04/08/2004 | US20040067202 Novel alkanoic acid derivaties |
| 04/08/2004 | DE20217814U1 Melatonin-Tagesdosierungseinheiten Melatonin daily dosage units |
| 04/08/2004 | DE10245525A1 Sustained release parenteral formulation used for ionic peptide drugs, useful e.g. for treating hormone dependent diseases, comprises active agent mixed with aqueous salt solution at specific concentrations |
| 04/08/2004 | DE10245212A1 Säurehaltige Desensibilisierungsmittel für Zähne Acidic desensitizing agent for teeth |
| 04/08/2004 | CA2633589A1 Perivascular wraps |
| 04/08/2004 | CA2501009A1 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof |
| 04/08/2004 | CA2500218A1 Drug absorptivity improving agent |
| 04/08/2004 | CA2500189A1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-.beta. |
| 04/08/2004 | CA2500067A1 Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
| 04/08/2004 | CA2499580A1 Novel agents that modulate eph receptor activity |
| 04/08/2004 | CA2497767A1 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 04/08/2004 | CA2497763A1 Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy |
| 04/07/2004 | EP1405863A1 Concentrate of a factor VIII:C-containing von-Willebrand-factor and a process for producing it |
| 04/07/2004 | EP1405644A1 Tissue-specific transporter inhibitor |
| 04/07/2004 | EP1404873A2 Chimeric immunomodulatory compounds and methods of using the same |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404841A2 Cyp1b1 nucleic acids and methods of use |
| 04/07/2004 | EP1404806A1 Male contraceptives |
| 04/07/2004 | EP1404784A1 Process for the production of medicinal white oil using m41s and sulfur sorbent |
| 04/07/2004 | EP1404719A1 Superabsorber, method for the production and use thereof |
| 04/07/2004 | EP1404516A2 Microencapsulation of drugs by solvent exchange |
| 04/07/2004 | EP1404413A2 Dermatological formulations |
| 04/07/2004 | EP1404377A2 Improved chelator conjugates |
| 04/07/2004 | EP1404373A2 Pna conjugate for the treatment of diseases associated with hiv |
| 04/07/2004 | EP1404372A1 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404370A2 Ophthalmic compositions comprising hyaluronic acid |
| 04/07/2004 | EP1404363A2 Adjuvant composition for mucosal and injection delivered vaccines |
| 04/07/2004 | EP1404361A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404357A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 04/07/2004 | EP1404356A2 Cd10-activated prodrug compounds |
| 04/07/2004 | EP1404355A1 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404354A2 Chemically-modified progenipoietin conjugates |
| 04/07/2004 | EP1404353A2 Methods of using a hyaluronan receptor |
| 04/07/2004 | EP1404351A1 Carbohydrate modifying agent and drinks containing the modifying agent |
| 04/07/2004 | EP1404345A2 Skin-permeable selective cyclooxygenase-2 inhibitor composition |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404334A1 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404314A1 Aerosol formulations of delta 8 tetrahydrocannabinol |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | EP1404306A1 A coated nicotine-containing chewing gum, manufacture and use thereof |
| 04/07/2004 | EP1404305A1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 04/07/2004 | EP1404303A1 Stable pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404301A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404300A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 04/07/2004 | EP1404299A2 Particles for inhalation having rapid release properties |
| 04/07/2004 | EP1404298A2 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1404294A2 Biodegradable polymer composition |
| 04/07/2004 | EP1404291A1 Water-free ubichinon concentrate |
| 04/07/2004 | EP1404281A1 Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries |
| 04/07/2004 | EP1404264A2 Insert for the treatment of dry eye |
| 04/07/2004 | EP1404178A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 04/07/2004 | EP1404174A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/07/2004 | EP1303267B1 Dermal for amino laevulinic acid |
| 04/07/2004 | EP1158964B1 Edible coating composition |
| 04/07/2004 | EP1156806B1 Pharmaceutical composition containing proton pump inhibitors |
| 04/07/2004 | EP1147148A4 Dextran-maleic acid monoesters and hydrogels based thereon |
| 04/07/2004 | EP1128820B1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 04/07/2004 | EP1105401B1 Phosphoglycolipid and methods for its use |
| 04/07/2004 | EP1105123B1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 04/07/2004 | EP1087783B1 Use of gastrin fragments or synthetic analogs of gastrin for the manufacture of a medicament for the treatment of helicobacter pylori-associated disorders |
| 04/07/2004 | EP1085907B1 Solution comprising prostaglandins and benzyl alcohol |
| 04/07/2004 | EP1028753B1 Delivery of poly (ethylene glycol) -conjugated molecules from degradable hydrogels |
| 04/07/2004 | EP0836511B1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/07/2004 | EP0789561B1 Oral cyclosporin formulations |
| 04/07/2004 | EP0771217B1 Solid drug forms containing clathrates of the steroid sex hormone ethinylestradiol |
| 04/07/2004 | EP0731812B1 METHOD FOR ISOLATING POLY-beta-1-4-N-ACETYLGLUCOSAMINE |
| 04/07/2004 | CN1487967A A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 04/07/2004 | CN1487854A Dehydrating agent and method for dehyclrating moist article using the agent and dehydrated article obtained by the method |
| 04/07/2004 | CN1487843A A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1487832A Novel method and compositions for local treatment of Meniere's disease, tinnitus and lor hearing loss |
| 04/07/2004 | CN1487828A New film coating |
| 04/07/2004 | CN1487827A Process for preparing non-hygroscopic sodium valproate composition |
| 04/07/2004 | CN1486695A Delayed releasing Acipimox prepn |
| 04/07/2004 | CN1144598C Stabilization of compositions containing ACE inhibitors using magnesium oxide |
| 04/07/2004 | CN1144592C Use of camptotheicin derivatives with reduced gastrointestinal toxicity |
| 04/07/2004 | CN1144585C Animal fast biochemical accelerating composition containing cysteamine and its salt and use |
| 04/07/2004 | CN1144584C Sustained-release compositions and method for preparing the same |
| 04/06/2004 | US6716970 Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof |
| 04/06/2004 | US6716968 Apoptosis-related antigenic compounds of specified amino acid sequence; inhibition of cell apoptosis; antibodies for stimulation of cell apoptosis; immunoassay to determine rate of apoptosis in tissues |